Lactiga is a biotherapeutics company advancing its patented biologics to transform the anti-infective sector and protect vulnerable patients
Lactiga is an award-winning, venture-backed biotherapeutics company developing novel biologics to treat and prevent infections with a focus on improving the quality of life in patients with Primary Immunodeficiency Diseases. We are unlocking the full therapeutic value of human milk to battle even the world’s most dangerous pathogens.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 21, 2022 | Grant | $350K | 2 | — | — | Detail |
Sep 21, 2022 | Pre-seed | $1.25M | 1 | 1517 Fund | — | Detail |
May 31, 2021 | Grant | $5K | 1 | — | — | Detail |
Dec 1, 2020 | Pre-seed | $1.40M | 4 | Checkmate Capital | — | Detail |
Sep 29, 2020 | Grant | $10K | 1 | LaunchYU | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
1517 Fund | Yes | Pre-seed |
Checkmate Capital | Yes | Pre-seed |
LaunchYU | Yes | Grant |
National Institutes of Health | Yes | Grant |
Innovation Factory (Canada) | — | Grant |
NJEDA | — | Grant |
Unnamed Investor | — | Grant |
Jude Gomila | — | Pre-seed |